(PharmaNewsWire.Com, May 23, 2017 ) Rabies is a condition that causes thousands of deaths worldwide every year. Humans contract rabies when bitten by an animal infected with the rabies virus. The virus is transmitted when the saliva of the infected animal touches an open wound or mucous membrane. It infects the brain and ultimately leads to death.
The rising awareness about animal health is one of the primary drivers for market growth. The growing awareness about animal health and the rising number of preventive vaccines is anticipated to drive the demand for animal rabies vaccines over the next four years. The most prominent segment of the global rabies treatment market is the livestock vaccine segment in the developed countries like the US and Europe. This is due to the rising awareness about the need to avoid the rabies infection in dogs and cattle. Numerous animal health programs have been taken up in various countries involving collaborations with private and government hospitals for the distribution of rabies vaccines along with the active vaccination of dogs. For instance, during 2012, two animal health awareness programs on the prevention and control of important livestock and zoonotic diseases were organized in Manipur, India. Moreover, the Indian government has also announced initiatives with the support of health agencies like WHO to control the spread of rabies from animals to humans. This increased level of animal disease awareness is foreseen to rise the demand and production of animal rabies vaccines.
In terms of geography, APAC dominated the global rabies treatment market during 2016 and is anticipated to continue the dominion over the next four years. The rising occurrences and mortality rates associated with human rabies and the increasing awareness about the vaccinations of dogs, will drive the market’s growth in this region.
The market is divided into the following segments based on geography: Americas APAC EMEA
Technavio's report, Global Rabies Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors Cadila Healthcare GlaxoSmithKline Merial Sanofi Other prominent vendors Merck Pfizer Market driver The need for contamination-free vaccines with novel culture media
For a full, detailed list, view our report
Market challenge High maintenance costs of vaccines For a full, detailed list, view our report
Market trend Introduction of monoclonal antibodies For a full, detailed list, view our report
Key questions answered in this report What will the market size be in 2021 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors?
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
Contact Us 90 State Street, Albany, NY 12207, United States Toll Free : 866-997-4948 (US-Canada) Tel : +1-518-621-2074 Email : press@marketresearchhub.com Website : http://www.marketresearchhub.com/
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
